98%
921
2 minutes
20
Introduction: Research suggests that migraine without aura (MwoA) is a risk factor for cervical artery dissection (CeAD); however, the association between migraine with aura (MwA) and CeAD remains inconclusive. We tested the coprimary hypotheses of positive associations between both MwA and MwoA and CeAD within two years following migraine diagnosis, compared to matched non-migraine controls, as measured by risk ratio (RR).
Methods: We queried de-identified US medical records data (TriNetX, LLC, Cambridge, Massachusetts, United States) spanning the years 2014-2024 to identify three cohorts of patients without previous CeAD. These included (1) individuals with a new diagnosis of MwA, (2) individuals with a new diagnosis of MwoA, and (3) non-migraine controls. Controlling for confounders, we created two 1:1 propensity-matched cohort pairs, having 217,390 patients (MwA versus controls) and 277,865 patients (MwoA versus controls).
Results: Compared to non-migraine controls, patients with either MwA or MwoA had an increased incidence and risk of CeAD: MwA (95% CI) (0.095% vs. 0.016%; RR=5.91 (4.13,8.46); p<0.0001) and MwoA (0.058% vs. 0.016%; RR=3.60 (2.59,5.01); p<0.0001).
Conclusion: Incidence and risk of vertebral and carotid artery dissections were similarly increased for both MwA and MwoA. Further research is needed to examine the pathophysiological mechanisms underlying the migraine-CeAD association, potential mediating factors, and temporal association between migraine attacks and CeAD.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12351512 | PMC |
http://dx.doi.org/10.7759/cureus.87883 | DOI Listing |
Alpha Psychiatry
August 2025
Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, 130021 Changchun, Jilin, China.
Background: The progressive legalization and widespread use of cannabis has led to its use as a treatment for certain neuropsychiatric disorders. Traditional epidemiological studies suggest that cannabis use has an effect on some neurocognitive aspects. However, it is unclear whether cannabis use is causally related to common neuropsychiatric disorders.
View Article and Find Full Text PDFEpileptic Disord
September 2025
Department of Neurology, Neurocritical Care and Neurorehabilitation, Christian Doppler University Hospital, Centre for Cognitive Neuroscience, Member of the European Reference Network EpiCARE, Paracelsus Medical University of Salzburg, Salzburg, Austria.
Mult Scler Relat Disord
September 2025
Neurologist-Neuroimmunologist. Associate Professor of Neurology, Neuroscience Department, Division of Neurology, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogotá, Colombia. Electronic address:
Background: Headache is a common but underrecognized symptom in optic neuritis (ON), with potential implications for diagnosis and management.
Objective: To assess the clinical and radiological factors associated with headache in patients with acute ON.
Methods: We conducted a retrospective case-control study in a tertiary hospital in Bogotá, Colombia (2022-2024).
JMIR Med Inform
September 2025
Division of Vascular Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.
Background: Deep learning has demonstrated significant potential in advancing computer-aided diagnosis for neuropsychiatric disorders, such as migraine, enabling patient-specific diagnosis at an individual level. However, despite the superior accuracy of deep learning models, the interpretability of image classification models remains limited. Their black-box nature continues to pose a major obstacle in clinical applications, hindering biomarker discovery and personalized treatment.
View Article and Find Full Text PDFFront Neurol
August 2025
Department of Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Objective: Sex hormones play a key role in migraine pathophysiology, yet their impact in men remains unclear. This study investigates sex hormone profiles and their potential relationship with Calcitonin Gene-Related Peptide (CGRP) in men with episodic migraine.
Methods: We analyzed serum blood levels of sex hormones testosterone, estradiol (E2), progesterone, follicle-stimulating hormone (FSH), luteinizing hormone (LH) and CGRP in age and body mass index (BMI)-matched men with and without migraine.